Skip to main content

RHOFADE: No Longer Covered

Effective January 1, 2018, RHOFADE will no longer be covered under your patients’ pharmacy benefit. The US Food and Drug Administration approved RHOFADE on January 19, 2017 to treat facial redness due to rosacea. Such use is deemed to be cosmetic and is not medically necessary nor appropriate. Letters were sent to impacted Horizon BCBSNJ members on December 1, 2017 notifying them of this change.

RHOFADE is a registered trademark of Allergan, Inc.

Published on: November 28, 2017, 05:19 a.m. ET
Last updated on: December 4, 2017, 10:15 a.m. ET